ALKS

$0.00

(

0.00%

)
Quote details

stock

Alkermes Plc

NASDAQ | ALKS

26.97

USD

$0.00

(

0.00%

)

At Close (As of Sep 12, 2025)

$4.45B

Market Cap

13.03

P/E Ratio

2.07

EPS

$36.45

52 Week High

$25.16

52 Week Low

HEALTHCARE

Sector

ALKS Chart

Recent Chart
Price Action

ALKS Technicals

Tags:

ALKS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.3B
Total Revenue $1.6B
Cost Of Revenue $245M
Costof Goods And Services Sold $245M
Operating Income $421M
Selling General And Administrative $199M
Research And Development $245M
Operating Expenses $892M
Investment Income Net -
Net Interest Income $20M
Interest Income $42M
Interest Expense $23M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $29M
Income Before Tax $444M
Income Tax Expense $72M
Interest And Debt Expense -
Net Income From Continuing Operations $372M
Comprehensive Income Net Of Tax -
Ebit $466M
Ebitda $495M
Net Income $367M

Revenue & Profitability

Earnings Performance

ALKS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $2.1B
Total Current Assets $1.4B
Cash And Cash Equivalents At Carrying Value $291M
Cash And Short Term Investments $291M
Inventory $183M
Current Net Receivables $390M
Total Non Current Assets $640M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $890K
Intangible Assets Excluding Goodwill $890K
Goodwill $83M
Investments -
Long Term Investments $73M
Short Term Investments $461M
Other Current Assets $91M
Other Non Current Assets -
Total Liabilities $591M
Total Current Liabilities $465M
Current Accounts Payable $46M
Deferred Revenue -
Current Debt -
Short Term Debt $12M
Total Non Current Liabilities $125M
Capital Lease Obligations $76M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $76M
Other Current Liabilities $406M
Other Non Current Liabilities $56M
Total Shareholder Equity $1.5B
Treasury Stock -
Retained Earnings -$976M
Common Stock $1.8M
Common Stock Shares Outstanding $169M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $439M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $29M
Capital Expenditures $33M
Change In Receivables -
Change In Inventory $3.1M
Profit Loss -
Cashflow From Investment -$111M
Cashflow From Financing -$494M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$200M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $367M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.3B
Total Revenue $1.6B
Cost Of Revenue $245M
Costof Goods And Services Sold $245M
Operating Income $421M
Selling General And Administrative $199M
Research And Development $245M
Operating Expenses $892M
Investment Income Net -
Net Interest Income $20M
Interest Income $42M
Interest Expense $23M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $29M
Income Before Tax $444M
Income Tax Expense $72M
Interest And Debt Expense -
Net Income From Continuing Operations $372M
Comprehensive Income Net Of Tax -
Ebit $466M
Ebitda $495M
Net Income $367M

ALKS News

ALKS Profile

Alkermes Plc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland.

OPI
+78.58%
$0.55
WBD
+16.69%
$18.87
ATCH
+53.36%
$0.39
CGBS
-39.47%
$0.03
NXTT
-57.40%
$0.15
TSLA
+7.35%
$395.94
BITF
+9.31%
$2.23
NVDA
+0.36%
$177.82
YAAS
+6.17%
$0.07
AGAE
+62.44%
$1.48
RGTI
+14.37%
$19.09
GRAB
+8.49%
$6.00
AIRE
+17.88%
$1.45
SNAP
+0.68%
$7.34
AAL
-0.30%
$12.91
COCP
+9.72%
$1.58
PFE
-3.98%
$23.87
GSIW
-5.25%
$0.13
JOBY
+2.33%
$14.00
NIO
+2.47%
$6.22
VSTD
+65.11%
$2.13
TPIC
-45.91%
$0.12
MARA
+3.81%
$16.30
GCTK
+117.45%
$10.59
ISPC
+47.72%
$1.95
IONQ
+18.19%
$55.61
BMNR
+15.27%
$55.09
AXDX
-61.36%
$0.03
RIVN
-3.65%
$13.46
ADAP
+10.89%
$0.05
SOFI
+2.27%
$26.55
QBTS
+7.50%
$17.76
DNN
-2.46%
$2.37
BBD
-0.94%
$3.13
MULN
-17.14%
$0.06
BINI
-17.14%
$0.06
AAPL
+1.75%
$234.07
PLTR
+4.30%
$171.43
LYT
-16.77%
$0.09
INTC
-2.15%
$24.08
ORCL
-5.09%
$292.18
RAYA
+7.00%
$0.04
WLDS
+16.15%
$9.42
F
-0.68%
$11.68
ONDS
+2.18%
$6.56
TLRY
+5.66%
$1.12
SOUN
-3.15%
$14.12
AMD
+1.86%
$158.57
PLRZ
+22.76%
$1.20
BTG
+0.89%
$4.49
RMBL
+60.50%
$3.21
QS
+12.42%
$9.94
ORIS
+6.29%
$0.13
AMZN
-0.78%
$228.15
ABEV
+0.43%
$2.29
ADD
-25.47%
$0.05
SMCI
+2.38%
$45.00
HOOD
-2.31%
$115.03
IXHL
+3.30%
$0.54
HIMS
+7.22%
$55.50
SRM
+53.27%
$10.30
RR
+2.01%
$3.28
APLD
+8.73%
$18.68
CIFR
+8.82%
$10.85
CRWV
-0.64%
$111.96
MU
+4.42%
$157.22
MJID
+7.69%
$1.26
RZLV
-0.44%
$6.76
RIOT
+0.49%
$15.72
AVGO
+0.06%
$359.87
BTBT
+0.84%
$2.97
ETHD
-10.88%
$3.03
ACHR
+3.06%
$8.75
LYFT
+1.63%
$18.62
PSKY
+7.30%
$18.73
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CVE
-0.17%
$16.87
ITUB
-1.55%
$6.97
QUBT
+7.04%
$17.01
WLGS
-5.57%
$0.04
NVTS
+1.23%
$6.15
SBET
+8.19%
$17.70
WULF
+1.12%
$10.76
RKLB
+10.13%
$53.34
BAC
-0.33%
$50.58
HL
+0.53%
$11.21
PLUG
+0.66%
$1.52
PCG
-1.78%
$15.45
GOOGL
+0.17%
$240.80
KVUE
+0.74%
$18.98
JBLU
-2.88%
$5.05
ETWO
0.00%
$3.30
BIAF
+5.92%
$0.27
RIG
+1.22%
$3.30
VALE
+0.37%
$10.67
TSLG
+14.55%
$8.50
AG
+1.53%
$10.55
CAN
+0.56%
$0.82
BURU
+10.16%
$0.16
OPI
+78.58%
$0.55
WBD
+16.69%
$18.87
ATCH
+53.36%
$0.39
CGBS
-39.47%
$0.03
NXTT
-57.40%
$0.15
TSLA
+7.35%
$395.94
BITF
+9.31%
$2.23
NVDA
+0.36%
$177.82
YAAS
+6.17%
$0.07
AGAE
+62.44%
$1.48
RGTI
+14.37%
$19.09
GRAB
+8.49%
$6.00
AIRE
+17.88%
$1.45
SNAP
+0.68%
$7.34
AAL
-0.30%
$12.91
COCP
+9.72%
$1.58
PFE
-3.98%
$23.87
GSIW
-5.25%
$0.13
JOBY
+2.33%
$14.00
NIO
+2.47%
$6.22
VSTD
+65.11%
$2.13
TPIC
-45.91%
$0.12
MARA
+3.81%
$16.30
GCTK
+117.45%
$10.59
ISPC
+47.72%
$1.95
IONQ
+18.19%
$55.61
BMNR
+15.27%
$55.09
AXDX
-61.36%
$0.03
RIVN
-3.65%
$13.46
ADAP
+10.89%
$0.05
SOFI
+2.27%
$26.55
QBTS
+7.50%
$17.76
DNN
-2.46%
$2.37
BBD
-0.94%
$3.13
MULN
-17.14%
$0.06
BINI
-17.14%
$0.06
AAPL
+1.75%
$234.07
PLTR
+4.30%
$171.43
LYT
-16.77%
$0.09
INTC
-2.15%
$24.08
ORCL
-5.09%
$292.18
RAYA
+7.00%
$0.04
WLDS
+16.15%
$9.42
F
-0.68%
$11.68
ONDS
+2.18%
$6.56
TLRY
+5.66%
$1.12
SOUN
-3.15%
$14.12
AMD
+1.86%
$158.57
PLRZ
+22.76%
$1.20
BTG
+0.89%
$4.49
RMBL
+60.50%
$3.21
QS
+12.42%
$9.94
ORIS
+6.29%
$0.13
AMZN
-0.78%
$228.15
ABEV
+0.43%
$2.29
ADD
-25.47%
$0.05
SMCI
+2.38%
$45.00
HOOD
-2.31%
$115.03
IXHL
+3.30%
$0.54
HIMS
+7.22%
$55.50
SRM
+53.27%
$10.30
RR
+2.01%
$3.28
APLD
+8.73%
$18.68
CIFR
+8.82%
$10.85
CRWV
-0.64%
$111.96
MU
+4.42%
$157.22
MJID
+7.69%
$1.26
RZLV
-0.44%
$6.76
RIOT
+0.49%
$15.72
AVGO
+0.06%
$359.87
BTBT
+0.84%
$2.97
ETHD
-10.88%
$3.03
ACHR
+3.06%
$8.75
LYFT
+1.63%
$18.62
PSKY
+7.30%
$18.73
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CVE
-0.17%
$16.87
ITUB
-1.55%
$6.97
QUBT
+7.04%
$17.01
WLGS
-5.57%
$0.04
NVTS
+1.23%
$6.15
SBET
+8.19%
$17.70
WULF
+1.12%
$10.76
RKLB
+10.13%
$53.34
BAC
-0.33%
$50.58
HL
+0.53%
$11.21
PLUG
+0.66%
$1.52
PCG
-1.78%
$15.45
GOOGL
+0.17%
$240.80
KVUE
+0.74%
$18.98
JBLU
-2.88%
$5.05
ETWO
0.00%
$3.30
BIAF
+5.92%
$0.27
RIG
+1.22%
$3.30
VALE
+0.37%
$10.67
TSLG
+14.55%
$8.50
AG
+1.53%
$10.55
CAN
+0.56%
$0.82
BURU
+10.16%
$0.16

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.